Medication Tapering and Withdrawal· 15 min read

Klonopin Withdrawal: Symptoms, Timeline, and How to Taper Safely

Coming Off Klonopin: What to Expect

Updated October 2026. Label facts are from the Klonopin prescribing information revised January 2023.

Klonopin withdrawal is a group of symptoms, such as anxiety, trouble sleeping, irritability and tremor, that can appear when you lower or stop Klonopin after regular use. Klonopin is the brand name for clonazepam (Klonopin prescribing information).

I’m a board-certified psychiatrist practicing in North Carolina, and I supervise benzodiazepine tapers, including Klonopin.

In 2025, the American Society of Addiction Medicine and nine other medical societies and professional associations published a joint guideline on benzodiazepine tapering. It calls physical dependence an expected outcome of regular benzodiazepine use. It treats dependence as separate from a benzodiazepine use disorder (Brunner et al., 2025).

Don’t stop Klonopin suddenly or cut the dose on your own. The label warns that stopping suddenly or lowering the dose quickly after continued use may cause withdrawal reactions that can be life-threatening, including seizures (Klonopin prescribing information).

The guideline says most tapers can be managed outside the hospital, with regular check-ins (Brunner et al., 2025).

Klonopin Withdrawal at a Glance

  1. Clonazepam leaves the body slowly. The label gives a typical half-life of 30 to 40 hours (Klonopin prescribing information). A 1987 review reported a range of 20 to 80 hours (Greenblatt et al., 1987).
  2. Klonopin is a long half-life benzodiazepine. One trial studied people who had taken a benzodiazepine every day for more than a year and then stopped suddenly. Withdrawal from long half-life benzodiazepines peaked 4 to 7 days after the last dose (Rickels et al., 1990).
  3. Withdrawal symptoms listed on the label include anxiety, insomnia, irritability, tremor, muscle pain and panic attacks (Klonopin prescribing information).
  4. The label says protracted withdrawal symptoms may last weeks to more than 12 months in some people (Klonopin prescribing information).
  5. The 2025 guideline recommends a first step of 5% to 10% of the dose, and a pace that usually isn’t faster than 25% every 2 weeks (Brunner et al., 2025).
  6. If withdrawal symptoms appear during a taper, the label tells prescribers to consider pausing the taper or going back to the previous dose, and then lowering the dose more slowly (Klonopin prescribing information).

My page on supervised tapering in North Carolina explains how a taper with me works.

Why Klonopin Withdrawal Happens

Clonazepam acts at the benzodiazepine binding site on the brain’s GABA-A receptors. Its acute effects track the share of those receptors it occupies (Greenblatt et al., 1987).

The label says continued use of clonazepam may lead to clinically significant physical dependence. In a person with physical dependence, stopping suddenly or lowering the dose quickly can cause withdrawal reactions. The risk is higher at higher doses and with longer use (Klonopin prescribing information).

In 2020, the FDA required an updated Boxed Warning for every benzodiazepine. It covers abuse, misuse, addiction, physical dependence and withdrawal reactions (FDA, 2020).

How often withdrawal happens depends on how it’s measured. The 1990 trial of sudden stops studied people who had taken a benzodiazepine every day for more than a year. After a switch to placebo, 58% to 100% had a withdrawal reaction, depending on the criteria used (Rickels et al., 1990).

A 1994 review noted that it isn’t clear what share of people on regular therapeutic doses will have a withdrawal syndrome (Pétursson, 1994).

The label asks for a gradual taper to reduce the risk of withdrawal reactions (Klonopin prescribing information).

Antidepressants can cause withdrawal symptoms too. My guide to antidepressant discontinuation syndrome covers them.

How Long Klonopin Stays in Your System

A saffron-gold curve on a navy base rises fast and falls in a long, slow tail, showing how long Klonopin (clonazepam) stays in your system

The label gives a typical half-life of 30 to 40 hours for clonazepam (Klonopin prescribing information). In a study of 9 healthy volunteers, the average half-life was 40 hours (Greenblatt et al., 2005).

A 1987 review reported a range of 20 to 80 hours, so two people on the same dose can clear it at different speeds (Greenblatt et al., 1987).

Blood levels peak 1 to 4 hours after a dose (Klonopin prescribing information). With regular dosing, clonazepam builds up.

In the 2005 study, blood levels at steady state were about 3.3 times the levels on the first day. That matches what the half-life predicts (Greenblatt et al., 2005).

Each half-life halves the amount left. At a half-life of 30 to 40 hours, about 5 half-lives, or roughly 6 to 8 days, pass before only about 3% of a dose remains.

Clonazepam’s breakdown products don’t appear to have important drug activity (Greenblatt et al., 1987). Less than 2% of a dose leaves the body unchanged in the urine (Klonopin prescribing information).

In the 1990 trial of sudden stops, short half-life benzodiazepines caused more severe withdrawal than long half-life ones. Withdrawal from the long half-life drugs also peaked later (Rickels et al., 1990).

Klonopin Withdrawal Symptoms

The label lists withdrawal symptoms that include anxiety, insomnia, irritability, depersonalization, derealization, sensitivity to sound and light, a fast heartbeat, tremor, muscle pain and stiffness, panic attacks and memory problems (Klonopin prescribing information).

A 1994 review added sweating, trouble concentrating, nausea, palpitations, headache and changes in perception (Pétursson, 1994).

The label also lists severe reactions, including seizures and psychosis (Klonopin prescribing information). The Klonopin Medication Guide says stopping Klonopin suddenly can cause seizures that will not stop, called status epilepticus (Klonopin prescribing information).

Some people have symptoms that last beyond 4 to 6 weeks. The label calls this protracted withdrawal. It describes anxiety, trouble thinking clearly, depression, insomnia, a crawling feeling on the skin, muscle weakness or twitching, tingling and ringing in the ears (Klonopin prescribing information).

The label says protracted withdrawal symptoms may last weeks to more than 12 months (Klonopin prescribing information). How often this happens isn’t known. The 2025 guideline describes it in a subset of patients and says its mechanism hasn’t been established (Brunner et al., 2025).

My guide to post-acute withdrawal syndrome covers long withdrawal after antidepressants.

Klonopin Withdrawal Timeline

A flip calendar on a navy stand with blank pages turning forward, beside a small clonazepam tablet, illustrating the Klonopin withdrawal timeline over days and weeks

The peak timing in this table comes from people who stopped a benzodiazepine suddenly (Rickels et al., 1990).

StageWhat to expect
ReboundShort-lived rebound anxiety and insomnia can start within 1 to 4 days of stopping, depending on the drug’s half-life (Pétursson, 1994)
Peak after a sudden stopDays 4 to 7 for long half-life benzodiazepines (Rickels et al., 1990). Clonazepam is a long half-life benzodiazepine.
Usual endThe full withdrawal syndrome usually lasts 10 to 14 days (Pétursson, 1994)
Longer courseProtracted symptoms continue beyond 4 to 6 weeks and may last weeks to more than 12 months in some people (Klonopin prescribing information)

Your own course depends partly on your dose and how long you’ve taken Klonopin (Klonopin prescribing information).

How to Taper Off Klonopin: What the 2025 Guideline Recommends

A navy blister card of clonazepam orally disintegrating tablets with the foil peeling back and one tablet lifting out, beside a scored tablet, illustrating the small dose forms used to taper off Klonopin

The 2025 joint guideline says a benzodiazepine shouldn’t be stopped abruptly in someone who’s likely to be physically dependent. It recommends a first step of 5% to 10% of the dose. After that, the pace usually shouldn’t be faster than 25% every 2 weeks (Brunner et al., 2025).

Each step can be a share of the current dose, so the steps get smaller as the dose falls. The guideline calls this hyperbolic tapering. It also recommends smaller steps near the end of a taper (Brunner et al., 2025).

After years of daily use, a taper can take a year or more (Brunner et al., 2025).

The guideline’s own review found no trials that compared one tapering schedule with another (Brunner et al., 2025). Its pace recommendations come from the studies that exist and from expert consensus.

A 1990 trial tested a faster pace. Adults on long-term benzodiazepine treatment lowered their dose by 25% each week.

Ninety percent had a withdrawal reaction, and most reactions were mild to moderate. Among people on long half-life drugs, 32% couldn’t reach a drug-free state (Schweizer et al., 1990).

In that trial, the second half of the taper was harder than the first half (Schweizer et al., 1990).

The label supports a flexible pace. If withdrawal symptoms appear, it tells prescribers to consider pausing the taper or returning to the previous dose, and then to lower the dose more slowly (Klonopin prescribing information). The guideline adds that a pause or a slower pace should come before adding another medication (Brunner et al., 2025).

I plan each Klonopin taper around why you take it, how long you’ve taken it, how earlier dose changes went and what other medications you take. I hold each step until symptoms settle, and I plan the next step at the next visit.

Dose Forms and Small Steps

Dose formStrengthsNote
Klonopin and generic clonazepam tablets0.5, 1 and 2 mgThe 0.5 mg Klonopin tablet is scored (Klonopin prescribing information)
Clonazepam orally disintegrating tablets (ODT)0.125, 0.25, 0.5, 1 and 2 mgDissolves in the mouth (clonazepam ODT prescribing information)
Clonazepam liquidNoneNo FDA-labeled liquid on DailyMed (October 2026)
Compounded clonazepamMade by a compounding pharmacy to a prescribed strengthFor doses the tablets can’t make

The 0.125 mg and 0.25 mg ODT strengths make small steps possible. I use them when a step calls for a dose between the tablet strengths.

When a step needs a dose that no tablet can make, I can arrange compounded clonazepam.

Some taper plans switch from clonazepam to diazepam (Valium), another long-acting benzodiazepine. The guideline lists a switch to a longer-acting benzodiazepine as an option, and it names clonazepam itself as one of the longer-acting choices (Brunner et al., 2025). I decide on a switch to diazepam case by case.

If you’re in North Carolina and want help planning yours, you can book a free 15-minute consultation.

What Helps During a Taper

Adding cognitive behavioral therapy (CBT) to a taper helps in the short term.

In a Cochrane review, CBT plus a taper led to more successful stops than a taper alone within 4 weeks after treatment ended (risk ratio 1.40). The advantage was still there at the 3-month follow-up (risk ratio 1.51). The benefit was less certain at 6 months and later (Darker et al., 2015).

CBT for insomnia, often called CBT-I, helped in a trial of older adults who had taken a benzodiazepine for sleep for an average of 19 years. After the program, 85% of those who had a supervised taper plus CBT were benzodiazepine-free, compared with 48% after the taper alone (Morin et al., 2004).

One trial found no added benefit. In Dutch general practice, group CBT didn’t raise the success rate of a taper (58% with CBT, 62% without). The taper itself made a large difference: 62% stopped, compared with 21% with usual care (Oude Voshaar et al., 2003).

The 2025 guideline recommends offering psychosocial support alongside a taper (Brunner et al., 2025).

No medicine has strong evidence as a taper aid. A Cochrane review of 38 trials couldn’t draw firm conclusions about any of them (Baandrup et al., 2018). The guideline found no single medication with enough data to recommend (Brunner et al., 2025).

If you’ve read about the peptide Selank, my guide to peptides with psychiatric medications covers what’s known about it alongside benzodiazepines.

In the long-term follow-up of the Dutch trial, people who didn’t drink alcohol were more likely to stay off benzodiazepines (Oude Voshaar et al., 2006).

The label’s boxed warning says taking a benzodiazepine with an opioid may cause profound sedation, slowed breathing, coma and death (Klonopin prescribing information). The guideline recommends offering naloxone to anyone prescribed both (Brunner et al., 2025).

If you take Klonopin for sleep, my guide to sleep medications compares the prescription and nonprescription choices.

Withdrawal, Rebound, or Return of Anxiety?

Anxiety and poor sleep during a taper can come from withdrawal, from a short rebound, or from the original condition returning. A 1994 review described these three patterns (Pétursson, 1994).

PatternWhat it looks likeHow long it lasts
ReboundAnxiety and insomnia within 1 to 4 days of stopping, depending on the drug’s half-life (Pétursson, 1994)Short-lived (Pétursson, 1994)
Withdrawal syndromeSymptoms such as tremor, sweating and changes in perception (Pétursson, 1994). After a sudden stop of a long half-life benzodiazepine, it peaked at days 4 to 7 (Rickels et al., 1990)Usually 10 to 14 days (Pétursson, 1994)
Return of the original conditionThe anxiety symptoms that led to treatment come backThey persist until treatment starts (Pétursson, 1994)

The guideline treats symptoms that follow dose changes, or settle quickly after a pause, as more likely to be withdrawal (Brunner et al., 2025).

In the 1990 trial of sudden stops, people who stayed off benzodiazepines for at least 5 weeks had lower anxiety than before they stopped (Rickels et al., 1990).

If you take Klonopin for anxiety, my anxiety treatment in North Carolina page compares it with the other anxiety medicines.

Supervised Klonopin Tapering in North Carolina

I’m board-certified by the American Board of Psychiatry and Neurology in Psychiatry and Forensic Psychiatry. I plan Klonopin tapers by video for adults across North Carolina, and my page on supervised tapering in North Carolina explains how it works.

The FDA has approved clonazepam for panic disorder and for some seizure disorders (Klonopin prescribing information). If you take it for seizures, the clinician who treats your seizures should be part of any dose change. If you take it for panic or anxiety, a taper plan covers that condition as well as the withdrawal.

I see patients by video anywhere in North Carolina, and in person at my Wilmington office by request. A flat $350 a month covers up to two visits. Labs and medications are paid separately, and it’s month to month with no contract.

If you’re taking Klonopin and thinking about coming off, you can start with a free 15-minute consultation.

Frequently Asked Questions

What happens if I suddenly stop taking clonazepam?

The label warns that stopping suddenly after continued use may cause withdrawal reactions that can be life-threatening, including seizures. Its Medication Guide says a sudden stop can cause seizures that will not stop, called status epilepticus. Plan any change to your dose with your prescriber.

What day does Klonopin withdrawal peak?

In a 1990 trial of people who stopped suddenly after more than a year of daily use, withdrawal from long half-life benzodiazepines peaked at days 4 to 7. Clonazepam is a long half-life benzodiazepine. Withdrawal from short half-life benzodiazepines peaked at day 2.

How do I wean off 1 mg of clonazepam?

The 2025 guideline recommends a first step of 5% to 10% of the dose. After that, the pace usually isn’t faster than 25% every 2 weeks, and the steps get smaller near the end. Clonazepam orally disintegrating tablets come in strengths as low as 0.125 mg and 0.25 mg, and compounded clonazepam can make doses the tablets can’t. Your prescriber sets each step based on how the last one went.

Is 1 mg of Klonopin a day a lot?

The 2025 guideline classes up to 0.5 mg of clonazepam a day as a low dose and 0.5 to 1.5 mg a day as a moderate dose. By that scale, 1 mg a day is a moderate dose. For panic disorder, the label’s target dose for most patients is 1 mg a day.

Is it hard to stop taking 0.5 mg of clonazepam?

A dose of 0.5 mg a day falls in the guideline’s low-dose range. The label still asks for a gradual taper to stop Klonopin or lower the dose after continued use.

How long does it take to feel better after stopping clonazepam?

A 1994 review found that the full withdrawal syndrome usually lasts 10 to 14 days. Some people have protracted symptoms beyond 4 to 6 weeks. In a 1990 trial of sudden stops, people who stayed off benzodiazepines for at least 5 weeks had lower anxiety than before they stopped.

Should I switch from Klonopin to Valium to taper?

The 2025 guideline lists a switch to a longer-acting benzodiazepine as an option, and it names clonazepam itself as a longer-acting choice. I decide on a switch to diazepam case by case.

Is there a liquid form of clonazepam?

DailyMed lists no FDA-labeled clonazepam liquid (October 2026). The 0.125 mg and 0.25 mg orally disintegrating tablets allow small steps, and compounded clonazepam can make doses the tablets can’t.

Can a Klonopin taper be done outside the hospital?

The 2025 guideline says most benzodiazepine tapers can be managed in outpatient settings. It names virtual or phone check-ins as one way to monitor a taper.

Is Klonopin dependence the same as addiction?

The 2025 guideline calls physical dependence an expected outcome of regular benzodiazepine use. It treats dependence as separate from a benzodiazepine use disorder.

Thinking About Coming Off Klonopin?

I plan slow, supervised clonazepam tapers for adults across North Carolina, with small steps at the low end of the dose range.

Call (910) 612-6015

This article is for educational purposes and is not medical advice. It does not establish a clinician-patient relationship. Clonazepam tapering requires individual assessment and supervision by a prescriber. Do not start, stop, or change a dose of clonazepam or any medication without speaking to that prescriber. Stopping clonazepam suddenly can cause seizures. If you have a medical emergency, call 911 or go to an emergency room. If you are in crisis, call or text 988, the Suicide and Crisis Lifeline.

References (15)
  1. H2-Pharma, LLC. Klonopin (clonazepam) tablets, prescribing information and Medication Guide. Revised 1/2023; DailyMed version published December 2025. DailyMed
  2. Par Health USA. Clonazepam orally disintegrating tablets, prescribing information. Revised 02/2026. DailyMed
  3. U.S. National Library of Medicine. DailyMed search: clonazepam dosage forms. Searched 13 October 2026. DailyMed
  4. U.S. Food and Drug Administration. FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. Drug Safety Communication, 23 September 2020. FDA
  5. Brunner E, Chen CA, Klein T, et al. Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits. J Gen Intern Med. 2025;40(12):2814-2859. PMID 40526204
  6. Rickels K, Schweizer E, Case WG, Greenblatt DJ. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. Arch Gen Psychiatry. 1990;47(10):899-907. PMID 2222129
  7. Schweizer E, Rickels K, Case WG, Greenblatt DJ. Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper. Arch Gen Psychiatry. 1990;47(10):908-915. PMID 2222130
  8. Pétursson H. The benzodiazepine withdrawal syndrome. Addiction. 1994;89(11):1455-1459. PMID 7841856
  9. Greenblatt DJ, Miller LG, Shader RI. Clonazepam pharmacokinetics, brain uptake, and receptor interactions. J Clin Psychiatry. 1987;48 Suppl:4-11. PMID 2822672
  10. Greenblatt DJ, Blaskovich PD, Nuwayser ES, et al. Clonazepam pharmacokinetics: comparison of subcutaneous microsphere injection with multiple-dose oral administration. J Clin Pharmacol. 2005;45(11):1288-1293. PMID 16239362
  11. Darker CD, Sweeney BP, Barry JM, Farrell MF, Donnelly-Swift E. Psychosocial interventions for benzodiazepine harmful use, abuse or dependence. Cochrane Database Syst Rev. 2015;(5):CD009652. PMID 26106751
  12. Morin CM, Bastien C, Guay B, et al. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry. 2004;161(2):332-342. PMID 14754783
  13. Oude Voshaar RC, Gorgels WJ, Mol AJ, et al. Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial. Br J Psychiatry. 2003;182:498-504. PMID 12777340
  14. Oude Voshaar RC, Gorgels WJ, Mol AJ, et al. Predictors of long-term benzodiazepine abstinence in participants of a randomized controlled benzodiazepine withdrawal program. Can J Psychiatry. 2006;51(7):445-452. PMID 16838826
  15. Baandrup L, Ebdrup BH, Rasmussen JØ, et al. Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users. Cochrane Database Syst Rev. 2018;3(3):CD011481. PMID 29543325
Begin care

Schedule a free consultation

Dr. Shantanu Baghel

Shantanu Baghel

Board-certified · Psychiatry & Forensic Psychiatry

Dr. Baghel runs Baghel Psychiatry, a cash-pay practice that sees adults by video anywhere in North Carolina and in person at the Wilmington office by request. He focuses on the overlap between mood, hormones, and metabolism, and on supervised antidepressant discontinuation.

More writing

Begin

Get a Comprehensive Evaluation in North Carolina